chlorothiazide sodium
Chlorothiazide Sodium for Injection, USP(For Intravenous Use)
Approved
Approval ID
377dc515-e381-4196-8bc7-b738606c57ac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 14, 2021
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 796852890
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
chlorothiazide sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-305
Application NumberANDA202462
Product Classification
M
Marketing Category
C73584
G
Generic Name
chlorothiazide sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 16, 2020
FDA Product Classification
INGREDIENTS (3)
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
chlorothiazide sodiumActive
Quantity: 500 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM